Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Von Willebrand disease type 2M: Correlation between genotype and phenotype.
Maas DPMSM, Atiq F, Blijlevens NMA, Brons PPT, Krouwel S, Laros-van Gorkom BAP, Leebeek FWG, Nieuwenhuizen L, Schoormans SCM, Simons A, Meijer D, van Heerde WL, Schols SEM. Maas DPMSM, et al. Among authors: schoormans scm. J Thromb Haemost. 2022 Feb;20(2):316-327. doi: 10.1111/jth.15586. Epub 2021 Nov 21. J Thromb Haemost. 2022. PMID: 34758185 Free PMC article.
Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease.
Atiq F, Heijdra J, Snijders F, Boender J, Kempers E, van Heerde WL, Maas DPMSM, Krouwel S, Schoormans SC, de Meris J, Schols SEM, van Galen KPM, van der Bom JG, Cnossen MH, Meijer K, Fijnvandraat K, Eikenboom J, Leebeek FWG. Atiq F, et al. Blood Adv. 2022 Sep 27;6(18):5317-5326. doi: 10.1182/bloodadvances.2021006757. Blood Adv. 2022. PMID: 35446929 Free PMC article.
Importance of Genotyping in von Willebrand Disease to Elucidate Pathogenic Mechanisms and Variability in Phenotype.
Atiq F, Boender J, van Heerde WL, Tellez Garcia JM, Schoormans SC, Krouwel S, Cnossen MH, Laros-van Gorkom BAP, de Meris J, Fijnvandraat K, van der Bom JG, Meijer K, van Galen KPM, Eikenboom J, Leebeek FWG. Atiq F, et al. Hemasphere. 2022 May 11;6(6):e718. doi: 10.1097/HS9.0000000000000718. eCollection 2022 Jun. Hemasphere. 2022. PMID: 35747851 Free PMC article.
The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.
de Man FH, de Beer F, van der Laarse A, Jansen H, Leuven JA, Souverijn JH, Vroom TF, Schoormans SC, Fruchart JC, Havekes LM, Smelt AH. de Man FH, et al. Atherosclerosis. 2000 Dec;153(2):363-71. doi: 10.1016/s0021-9150(00)00409-3. Atherosclerosis. 2000. PMID: 11164425 Clinical Trial.